# Pulmonx (LUNG) — Earnings

LUNG · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/lung/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.24 |
| EPS estimate | −$0.25 |
| EPS surprise | +4.00% |
| Revenue surprise | +0.16% |
| Revenue | $22.8M |
| Revenue estimate | $22.7M |
| Reported | Jul 29, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1127537/000112753726000039/lung-20260630.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Jul 29, 2026 | −$0.25 | −$0.24 | 4.00% | $22.7M | $22.8M |
| Q1 2026 | Apr 29, 2026 | −$0.33 | −$0.33 | -1.01% | $20.4M | $20.6M |
| Q4 2025 | Mar 4, 2026 | −$0.39 | −$0.25 | 35.06% | $21.7M | $22.6M |
| Q3 2025 | Nov 12, 2025 | −$0.42 | −$0.34 | 19.43% | $21.0M | $21.5M |
| Q2 2025 | Jul 30, 2025 | −$0.39 | −$0.38 | 3.60% | $23.6M | $23.9M |
| Q1 2025 | Apr 30, 2025 | −$0.40 | −$0.36 | 9.98% | $22.0M | $22.5M |
| Q4 2024 | Feb 19, 2025 | −$0.45 | −$0.33 | 26.26% | $22.3M | $23.8M |
| Q3 2024 | Oct 30, 2024 | −$0.45 | −$0.36 | 19.73% | $20.3M | $20.4M |
| Q2 2024 | Jul 31, 2024 | −$0.42 | −$0.39 | 8.08% | $20.1M | $20.8M |
| Q1 2024 | May 1, 2024 | −$0.47 | −$0.36 | 23.32% | $18.0M | $18.9M |
| Q4 2023 | Feb 21, 2024 | −$0.41 | −$0.36 | 11.94% | $18.2M | $19.3M |
| Q3 2023 | Oct 30, 2023 | −$0.43 | −$0.39 | 8.86% | $16.7M | $17.7M |
| Q2 2023 | Aug 2, 2023 | −$0.44 | −$0.43 | 1.44% | $15.9M | $17.2M |
| Q1 2023 | May 2, 2023 | −$0.44 | −$0.42 | 4.55% | $13.5M | $14.5M |
| Q4 2022 | Feb 22, 2023 | −$0.42 | −$0.38 | 8.74% | $14.0M | $15.4M |
| Q3 2022 | Nov 3, 2022 | −$0.40 | −$0.38 | 4.19% | $14.9M | $13.5M |
| Q2 2022 | Aug 2, 2022 | −$0.41 | −$0.40 | 2.39% | $13.8M | $13.9M |
| Q1 2022 | May 3, 2022 | −$0.37 | −$0.43 | -15.84% | $9.3M | $10.8M |
| Q4 2021 | Feb 23, 2022 | −$0.36 | −$0.35 | 2.89% | $14.2M | $13.7M |
| Q3 2021 | Nov 2, 2021 | −$0.37 | −$0.28 | 24.77% | $13.2M | $13.3M |

## Frequently Asked Questions

### When did Pulmonx (LUNG) last report earnings?

Pulmonx last reported on Jul 29, 2026, covering fiscal Q2 2026.

### Did LUNG beat earnings estimates?

Yes. Pulmonx reported EPS of −$0.24 for Q2 2026 against a −$0.25 estimate — a 4.00% beat.

### How much revenue did LUNG report last quarter?

Pulmonx reported $22.8M in revenue for Q2 2026, against a consensus estimate of $22.7M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).